Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Regeneron and Parabilis Partner to Develop Antibody-Helicon Conjugates Across Multiple Therapeutic Areas

Tuesday, May 19, 2026

Regeneron Pharmaceuticals has announced a strategic research collaboration with Parabilis Medicines to discover and develop therapeutic candidates using Parabilis Helicon peptide platform

Elabscience Launches PolyHRP-Streptavidin Conjugate for ELISA Testing

Thursday, May 14, 2026

Elabscience has launched a selfdeveloped PolyHRPStreptavidin conjugate designed to improve the sensitivity of enzymelinked immunosorbent assay ELISA testing for lowabundance biomarker detection

Erasca Enters into Collaboration with Merck to Evaluate ERAS-0015 with KEYTRUDA in RAS-Mutant Solid Tumours

Tuesday, May 12, 2026

Erasca has entered into a clinical trial collaboration and supply agreement with Merck to evaluate ERAS in combination with KEYTRUDA for patients with RASmutant solid tumours

Hengrui Pharma Enters into Collaboration with Bristol Myers Squibb to Advance Innovative Therapies

Tuesday, May 12, 2026

Hengrui Pharma and Bristol Myers Squibb have entered into global strategic collaboration and licensing agreements to develop a portfolio of earlystage programmes across oncology haematology and immunology

Zai Lab Receives FDA Fast Track Status for DLL3-Targeting ADC in epNEC Treatment

Tuesday, May 12, 2026

Zai Lab has received Fast Track Designation from the US Food and Drug Administration for zocilurtatug pelitecan zoci formerly ZL an investigational DLLtargeting antibodydrug conjugate ADC

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development

Friday, May 08, 2026

Altasciences a fully integrated drug development solution company and Certara a global leader in modelinformed drug development MIDD today announced a strategic partnership to accelerate earlyphase development programs

Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets

Friday, May 08, 2026

Halozyme Therapeutics Inc announced the Company entered into a global collaboration and license agreement with GSK Under the collaboration GSK has licensed Halozymes ENHANZE drug delivery technology for the development and potential commercialization...

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Thursday, May 07, 2026

Roche announced today that it has entered into a definitive merger agreement to acquire PathAI a USbased company in digital pathology and AIpowered technology for pathology laboratories and the biopharma industry

Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer

Thursday, May 07, 2026

Artera the developer of multimodal artificial intelligence MMAIbased prognostic and predictive cancer tests today announced US Food and Drug Administration FDA clearance of ArteraAI Breast for use in patients with earlystage

FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media

Thursday, May 07, 2026

FUJIFILM Biosciences a global leader in the life science market and NextCell Pharma AB a clinicalstage company specializing in cell therapy using umbilical cord mesenchymal stromal cells MSC today announced a global commercial launch resulting from t...